Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Randomized, Observer-masked, Placebo-and Active-controlled, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost and Placebo in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension

NCT01868126 is registered in ClinicalTrials.gov with Santen Inc. as lead sponsor.

NCT NCT01868126
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01868126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Randomized, Observer-masked, Placebo-and Active-controlled, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost and Placebo in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Lead sponsor
Santen Inc.
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2013
Completion date
September 30, 2013
Enrollment
91 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

open-angle glaucoma or ocular hypertension